Ventaira Pharmaceuticals, Inc. (Ventaira) is engaged in the development and manufacture of respiratory care products for the healthcare markets. It develops innovative patient therapies and novel pulmonary drug delivery products using its patented technology Mystic. The company operates as a subsidiary of Battelle Memorial Institute. The company is headquartered in Ohio, the US.
The company develops inhaled drugs and drug delivery systems. Its delivery systems includes nebulizers, metered dose inhalers and dry powder inhalers. Its inhaled drugs includes fentanyl for the treatment of breakthrough pain and flucticasone for the treatment of asthma.